The STEP 1 trial showed semaglutide 2.4 mg led to 14.9% weight loss over 68 weeks, while SURMOUNT-1 showed tirzepatide achieved up to 20.9% weight reductionapproaching bariatric surgery outcomes.[6] The SELECT trial (17,604 patients) found semaglutide reduced cardiovascular death, non-fatal heart attack, and non-fatal stroke by 20% and all-cause mortality by 19%, suggesting direct cardioprotective effects beyond weight loss.[4] In STEP-HFpEF, semaglutide produced 13.3% weight loss in heart failure patients and improved symptoms and physical function
Advanced biotechnological strategies for industrial-scale production are explored alongside innovative delivery systems, such as emulsions, films, microcapsules, nanoliposomes, and nanoparticles, designed to enhance ASXs bioavailability and functional efficacy
May reduce subcutaneous fat in caloric surplus Improves nutrient partitioning and insulin sensitivity short-term Helps preserve lean mass during cuts While AVF remained unchanged, GH secretagogues promoted fat oxidation and muscle preservation in GH-deficient adults. Makimura et al., The Journal of Clinical Endocrinology & Metabolism 4
The only surprise here is the timing
Using of Glutasyl Injection Combipack may cause few side effects such as redness, pain, and swelling at the site of injection
